Dogwood State Bank (DSBX)
Market Cap | 296.03M |
Revenue (ttm) | 67.43M |
Net Income (ttm) | 5.87M |
Shares Out | 18.98M |
EPS (ttm) | 0.35 |
PE Ratio | 44.57 |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | n/a |
Average Volume | 3,404 |
Open | 15.40 |
Previous Close | 15.22 |
Day's Range | 15.40 - 15.60 |
52-Week Range | 12.75 - 17.00 |
Beta | 0.04 |
RSI | 66.45 |
Earnings Date | Jan 31, 2025 |
About Dogwood State Bank
Dogwood State Bank provides banking products and services for businesses, business owners, professionals, and their employees in North Carolina. It offers personal and business checking accounts; savings accounts; money market accounts; individual retirement accounts; and certificates of deposit. The company also provides business financing services, including business lines of credit and business term loans; personal lines of credit; overdraft protection services; credit cards; home equity lines; personal loans comprising automobile and truck ... [Read more]
Financial Performance
In 2024, Dogwood State Bank's revenue was $67.43 million, an increase of 38.97% compared to the previous year's $48.52 million. Earnings were $5.87 million, a decrease of -44.84%.
Financial StatementsNews
Dogwood State Bank Reports Fourth Quarter and Full Year 2024 Results
RALEIGH, N.C. , Jan. 23, 2025 /PRNewswire/ -- Dogwood State Bank (OTC: DSBX) ("Dogwood" or the "Bank") announced today its financial results for the three and twelve months ended December 31, 2024.
Dogwood Therapeutics Announces Patient Dosing in Phase 2b Trial Evaluating Halneuron® in Patients with Chemotherapy Induced Neuropathy (CINP) to Commence First Quarter of 2025
ATLANTA, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biopharmaceutical company focused on advancing first-in class, non-opioid, Nav...
Dogwood Therapeutics Announces Third Quarter 2024 Financial Results
- Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”) formed in October by combination of Virios Therapeutics, Inc. and Pharmagesic (Holdings) Inc., 100% parent company of Wex Pharmaceuticals, Inc. (the “Comb...
Dogwood Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Thursday, November 7, 2024
ATLANTA, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced today th...
Dogwood State Bank Reports Third Quarter 2024 Results and Successful Integration of Community First
RALEIGH, N.C. , Oct. 23, 2024 /PRNewswire/ -- Dogwood State Bank (OTC: DSBX) ("Dogwood" or the "Bank") announced today its financial results for the three and nine months ended September 30, 2024.
Dogwood State Bank Reports Higher Second Quarter 2024 Earnings Reflecting Strong Operating Momentum Heading into Community First Acquisition
RALEIGH, N.C. , July 30, 2024 /PRNewswire/ -- Dogwood State Bank (OTCQX: DSBX) ("Dogwood") announced today its financial results for the three and six months ended June 30, 2024 as it prepares to clos...